Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The purpose of this study is to evaluate the performance of a non-invasive olfactory device as a rapid indicator of COVID-19 in positive subjects.
Description: The subject's score on using the olfactory device will be compared to the PCR results (SARS-CoV-2 negative or positive) on COVID19 outpatients. As the smell test has a variable scale (0-5) the ideal cutoff will be determined to maximize these factors: Sensitivity Specificity Accuracy
Measure: sensitivity, specificity and accuracy Time: 24 hoursDescription: Repeatability will also be examined in a test-retest score conducted within 24 hours with a second device in which the sequence of the odorants is altered.
Measure: repeatability Time: 48 hoursDescription: The score with the olfactory device will also be compared to subjects' response to the question "Do you have a new loss of smell or taste?" (current standard).
Measure: validation Time: 24 hoursDescription: We will determine if 'asymptomatic' SARS-CoV-2 positive subjects experience a partial loss of smell (hyposmia) and if so determine the fraction of subjects in which this occurs. Sensitivity, specificity and accuracy will be measured.
Measure: asymptomatic sensitivity, specificity and accuracy Time: 24 hours